SPINA, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 4.814
EU - Europa 2.252
AS - Asia 1.909
SA - Sud America 364
Continente sconosciuto - Info sul continente non disponibili 325
AF - Africa 59
OC - Oceania 4
Totale 9.727
Nazione #
US - Stati Uniti d'America 4.672
SG - Singapore 714
RU - Federazione Russa 664
IT - Italia 544
CN - Cina 478
BR - Brasile 282
FI - Finlandia 241
HK - Hong Kong 162
VN - Vietnam 156
PL - Polonia 136
DE - Germania 135
FR - Francia 107
GB - Regno Unito 96
IE - Irlanda 83
UA - Ucraina 75
CA - Canada 70
JP - Giappone 69
BD - Bangladesh 56
KR - Corea 46
IN - India 42
BE - Belgio 39
AR - Argentina 30
MX - Messico 29
TR - Turchia 28
IQ - Iraq 25
AT - Austria 23
SE - Svezia 21
ES - Italia 18
NL - Olanda 18
EC - Ecuador 15
PK - Pakistan 14
RO - Romania 14
ZA - Sudafrica 13
CR - Costa Rica 12
CL - Cile 11
AZ - Azerbaigian 10
CI - Costa d'Avorio 10
ID - Indonesia 9
IR - Iran 9
JM - Giamaica 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
KE - Kenya 8
LT - Lituania 8
MY - Malesia 8
NP - Nepal 8
MA - Marocco 7
UZ - Uzbekistan 7
DZ - Algeria 6
HN - Honduras 6
JO - Giordania 6
PH - Filippine 6
PY - Paraguay 6
VE - Venezuela 6
GR - Grecia 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
GT - Guatemala 4
HU - Ungheria 4
IL - Israele 4
LB - Libano 4
AU - Australia 3
BH - Bahrain 3
EE - Estonia 3
KG - Kirghizistan 3
KW - Kuwait 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MM - Myanmar 3
PA - Panama 3
PE - Perù 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
SY - Repubblica araba siriana 2
TG - Togo 2
TW - Taiwan 2
AO - Angola 1
BS - Bahamas 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EU - Europa 1
HR - Croazia 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
Totale 9.402
Città #
Ashburn 779
Singapore 459
San Jose 401
Chandler 321
Fairfield 318
Houston 173
Hong Kong 157
Woodbridge 157
Seattle 151
Wilmington 144
Council Bluffs 138
Ann Arbor 124
Moscow 120
Cambridge 109
Palermo 107
Zgierz 102
New York 99
Beijing 98
Medford 83
Dublin 81
Los Angeles 69
Santa Clara 63
Ho Chi Minh City 57
Dallas 56
Tokyo 56
Des Moines 53
Altamura 49
Princeton 47
Lauterbourg 44
Jacksonville 39
Brussels 37
Nanjing 37
São Paulo 36
Boardman 34
Hanoi 34
Chicago 33
Helsinki 33
Lawrence 33
San Diego 28
Orem 27
Rome 27
Frankfurt am Main 25
Milan 24
Buffalo 23
Toronto 23
Venice 22
Denver 19
Chennai 18
London 18
Phoenix 18
Atlanta 17
Changsha 17
Warsaw 17
Brooklyn 16
Izmir 15
Manchester 15
Tulsa 15
Jiaxing 14
Munich 14
Nanchang 14
Hefei 13
The Dalles 13
Tianjin 13
Düsseldorf 12
Jinan 12
Kraków 12
Shenyang 12
Baghdad 11
Dearborn 11
Minamiyukigaya 11
Montreal 11
Nuremberg 11
Stockholm 11
Zhengzhou 11
Abidjan 10
Boston 10
Bremen 10
Columbus 10
Hebei 10
Johannesburg 10
Lappeenranta 10
Ludwigshafen am Rhein 10
Washington 10
Amsterdam 9
Baku 9
Da Nang 9
Memphis 9
Redwood City 9
San Giorgio delle Pertiche 9
Vienna 9
Brasília 8
Nairobi 8
Rio de Janeiro 8
San José 8
Shanghai 8
Turku 8
Haiphong 7
Ningbo 7
Paris 7
Philadelphia 7
Totale 5.750
Nome #
CLINICAL AND MOLECULAR CHARACTERIZATION OF HYPERCHOLESTEROLEMIC SICILIAN FAMILIES AND DESCRIPTION OF 3 NOVEL MUTATIONS IN THE LDLR GENE 303
A NOVEL APOB MUTATION IDENTIFIED BY EXOME SEQUENCING COSEGREGATES WITH STEATOSIS, LIVER CANCER AND HYPOCHOLESTEROLEMIA 301
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 273
Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population 263
RUOLO DEL POLIMORFISMO ILE148MET DEL GENE PNPLA3 NELLA STEATOSI ASSOCIATA ALLA IPOBETALIPOPROTEINEMIA FAMILIARE 261
PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study 260
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 259
LA LIPIDOMICA DELLA NON ALCOHOLIC FATTY LIVER DISEASE: ANALISI DELLA CINETICA DELL’ACIDO PALMITICO MEDIANTE L’USO DI UN ISOTOPO STABILE IN UN MODELLO IN VITRO 246
LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY ACIDS 245
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily 241
A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia. 231
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing 231
Metabolomic analysis of plasma from Alzheimer disease patients 227
Myristic acid is associated to low plasma HDL cholesterol levels in a Mediterranean population and increases HDL catabolism by enhancing HDL particles trapping to cell surface proteoglycans in a liver hepatoma cell model 218
NEXT GENERATION SEQUENCIN: A NEW METHODOLOGICAL APPROACH FOR THE MOLECULAR DIAGNOSIS OF GENETIC DYSLIPIDEMIAS 216
A novel mutation in the Lipase Maturaction Factor 1 (LMF-1)gene responsible for severe hypertriglyceridemia 212
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 212
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia 210
Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia 208
PREVALENCE OF ANGPTL3 AND APOB GENE MUTATIONS IN SUBJECTS WITH COMBINED HYPOLIPIDEMIA 205
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography 205
Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia 204
Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia 196
Clinical, molecular and functional characterization of two novel mutations associated to compound heterozygous FHBL 193
ΒETA ARRESTIN-2: A NEW “ACTOR” IN THE LDL-R ENDOCYTOSIS? 192
Automated untargeted stable isotope assisted lipidomics of liver cells on high glucose shows alteration of sphingolipid kinetics 191
INTERACTION OF THE INTRACELLULAR DOMAIN OF THE LOW DENSITY LIPOPROTEIN (LDL) RECPTOR WITH METALLOTHIONEIN2 (MT2). 190
DETECTION OF NEW GENES RESPONSIBLE OF FAMILIAL RECESSIVE HYPERCHOLESTEROLEMIA: PRELIMINARY DATA FROM AN EXOME SEQUENCING APPROACH 190
Homozygous familial hypobetalipoproteinemia: Two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature 180
Identification of a novel ANGPTL3 mutation splicing associeted to severe hypobetalipoproteinemia 178
Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients 173
Effectiveness and safety of lomitapide in a patient with familial chylomicronemia syndrome 170
Le ipertrigliceridemie severe primitive: studio biochimico e genetico-molecolare 168
VASCULOPROTECTIVE FUNCTION OF HDL FROM CETP-DEFICIENT SUBJECTS 167
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 158
DeepSRE: Identification of sterol responsive elements and nuclear transcription factors Y proximity in human DNA by Convolutional Neural Network analysis 157
Comparison of two polygenic risk score to identify non-monogenic primary hypocholesterolemias in a large cohort of Italian hypocholesterolemic subjects 152
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism 151
PCSK9-D374Y MEDIATED LDL-R DEGRADATION CAN BE FUNCTIONALLY INHIBITED BY EGF-A AND TRUNCATED EGF-A PEPTIDES. AN IN VITRO STUDY 143
MUTATION IN CANDIDATE GENES ACCOUNT FOR A SMALL MINORITY OF HYPOBETALIPOPROTEINEMIAS AND NGS ANALYSIS SUPPORT POLYGENICITY IN MUTATION-NEGATIVE PATIENTS 141
PREVALENCE OF STATIN INTOLERANCE IN A COHORT OF OUTPATIENTS IN A LIPID CLINIC 140
Do genetically determined very high and very low LDL levels contribute to Lp(a) plasma concentration? 137
MOLECULAR CHARACTERIZATION OF PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE WITH "EXTREME LDL-C PHENOTYPES" 137
TGF-β/VEGF-A Genetic Variants Interplay in Genetic Susceptibility to Non-Melanocytic Skin Cancer 131
Genetically determined hypercholesterolaemia results into premature leucocyte telomere length shortening and reduced haematopoietic precursors 130
EFFECTIVENESS AND SAFETY OF LOMITAPIDE IN A PATIENT WITH FAMILIAL CHYLOMICRONEMIA SYNDROME 125
IDENTIFICATION OF P.LEU167DEL APOE GENE MUTATION BY NEXT GENERATION SEQUENCING IN A LARGE HYPERCHOLESTEROLEMIC FAMILY 123
Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial 119
Echocardiographic Calcium Score of Aortic Valve Correlates with Coronary Artery Calcium Score in Heterozygous Familial Hypercholesterolemia 111
Lack of phenotypic additive effect of familial defective apolipoprotein B3531 in familial hypercholesterolaemia 102
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 85
Six genetic variants are associated with cardiovascular disease independently from canonical risk factors: a new method to refine GWAS results based on the UKBiobank phenotype database 66
Totale 9.727
Categoria #
all - tutte 33.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.173


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022439 0 0 0 8 10 19 20 25 69 120 40 128
2022/2023848 79 159 22 90 87 130 44 77 94 6 43 17
2023/2024398 17 59 24 70 22 98 28 18 3 1 5 53
2024/20251.035 8 89 102 70 36 48 107 79 71 126 127 172
2025/20263.601 271 125 163 301 415 594 479 378 268 315 117 175
2026/2027952 199 90 412 251 0 0 0 0 0 0 0 0
Totale 9.727